• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病患者的 HLA 配型相同的同胞骨髓移植是否应仅限于大型医疗中心?

Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?

作者信息

Horowitz M M, Przepiorka D, Champlin R E, Gale R P, Gratwohl A, Herzig R H, Prentice H G, Rimm A A, Ringdén O, Bortin M M

机构信息

Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.

出版信息

Blood. 1992 May 15;79(10):2771-4.

PMID:1586723
Abstract

There is substantial evidence that the volume of medical procedures in a hospital has an inverse relationship with mortality. We analyzed data for 1313 recipients of HLA-identical sibling bone marrow transplants for early leukemia (acute leukemia in first remission or chronic myelogenous leukemia in first chronic phase) to determine whether transplant outcome differed in small and large centers. Transplants were performed in 86 bone marrow transplant centers active between the years 1983 and 1988, which participated in the International Bone Marrow Transplant Registry. Twenty-one (24%) centers performed five or fewer allogeneic transplants per year during the study period; five (6%) performed more than 40 per year. After adjustment for differences in patient and disease characteristics, the relative risks of treatment-related mortality (1.53, P less than .01) and treatment failure (1.38, P less than .04) were higher among patients who received transplants at centers doing five or fewer transplants per year than among those at larger centers. Among patients receiving transplants in centers performing more than five transplants a year, there was no statistically significant correlation between number of transplants and outcome.

摘要

有大量证据表明,医院的医疗程序数量与死亡率呈负相关。我们分析了1313例接受 HLA 相同同胞骨髓移植治疗早期白血病(首次缓解期的急性白血病或慢性期的慢性粒细胞白血病)患者的数据,以确定大小不同的中心移植结果是否存在差异。移植手术在1983年至1988年间活跃的86个参与国际骨髓移植登记处的骨髓移植中心进行。在研究期间,21个(24%)中心每年进行5例或更少的同种异体移植;5个(6%)中心每年进行超过40例。在对患者和疾病特征差异进行调整后,每年进行5例或更少移植的中心接受移植的患者,其治疗相关死亡率(1.53,P<0.01)和治疗失败率(1.38,P<0.04)的相对风险高于大型中心的患者。在每年进行超过5例移植的中心接受移植的患者中,移植数量与结果之间无统计学显著相关性。

相似文献

1
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?白血病患者的 HLA 配型相同的同胞骨髓移植是否应仅限于大型医疗中心?
Blood. 1992 May 15;79(10):2771-4.
2
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission.
Leukemia. 1996 Nov;10(11):1687-91.
3
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.使用 HLA 配型相合同胞以外的供者进行白血病异基因骨髓移植的结果。
J Clin Oncol. 1997 May;15(5):1767-77. doi: 10.1200/JCO.1997.15.5.1767.
4
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.年轻慢性淋巴细胞白血病患者的 HLA 全相合同胞异基因骨髓移植。欧洲血液和骨髓移植组及国际骨髓移植登记处。
Ann Intern Med. 1996 Feb 1;124(3):311-5. doi: 10.7326/0003-4819-124-3-199602010-00005.
5
Identical-twin bone marrow transplants for leukemia.用于治疗白血病的同卵双胞胎骨髓移植。
Ann Intern Med. 1994 Apr 15;120(8):646-52. doi: 10.7326/0003-4819-120-8-199404150-00004.
6
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.对非遗传母体抗原的耐受性对来自父母或 HLA 单倍型相同同胞的骨髓移植后移植物抗宿主病发生情况的影响。
Blood. 2002 Mar 1;99(5):1572-7. doi: 10.1182/blood.v99.5.1572.
7
Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. A report from the International Bone Marrow Transplant Registry.
Am J Pediatr Hematol Oncol. 1993 Feb;15(1):56-64. doi: 10.1097/00043426-199302000-00006.
8
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.HLA不相容性对白血病或淋巴瘤患者骨髓移植后移植物抗宿主病、复发及生存的影响。
Hum Immunol. 1990 Oct;29(2):79-91. doi: 10.1016/0198-8859(90)90071-v.
9
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
Blood. 2000 Jun 15;95(12):3996-4003.
10
Alternative donor transplants for leukemia. Scientific Advisory Committee of the International Bone Marrow Transplant Registry.白血病的替代供体移植。国际骨髓移植登记处科学咨询委员会。
Bone Marrow Transplant. 1993;11 Suppl 1:66-7.

引用本文的文献

1
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy.接受强化化疗的成年急性髓系白血病患者中,医院治疗量与总生存率之间的关联。
ESMO Open. 2025 Feb;10(2):104152. doi: 10.1016/j.esmoop.2025.104152. Epub 2025 Jan 30.
2
The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia.中心经验对急性髓细胞白血病异基因造血细胞移植结局的影响。
Bone Marrow Transplant. 2024 Apr;59(4):541-549. doi: 10.1038/s41409-024-02222-5. Epub 2024 Feb 6.
3
Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT.
国家特定社会经济因素与异基因造血细胞移植后发生严重经典急性移植物抗宿主病患者生存的相关性。来自 EBMT 移植并发症工作组的分析。
Front Immunol. 2020 Jul 23;11:1537. doi: 10.3389/fimmu.2020.01537. eCollection 2020.
4
[DKG certification of paediatric cancer centres - a wide field …].[儿科癌症中心的DKG认证——一个广泛的领域……]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):475-481. doi: 10.1007/s00103-020-03112-z.
5
Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults.成人异基因造血细胞移植后的移植中心特征和生存情况。
Bone Marrow Transplant. 2020 May;55(5):906-917. doi: 10.1038/s41409-019-0748-1. Epub 2019 Nov 18.
6
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals.美国医院造血细胞移植后 30 天内非计划性再入院的相关因素。
JAMA Netw Open. 2019 Jul 3;2(7):e196476. doi: 10.1001/jamanetworkopen.2019.6476.
7
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900).临床试验入组数量与急性髓系白血病结局的关系:SWOG/ECOG-ACRIN 研究(S0106 和 E1900)。
Leuk Res. 2019 Mar;78:29-33. doi: 10.1016/j.leukres.2019.01.007. Epub 2019 Jan 17.
8
Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.宏观经济因素与成人急性淋巴细胞白血病异基因造血细胞移植后非复发死亡率的关联:来自欧洲血液与骨髓移植协会急性白血病工作组的分析
Oncologist. 2016 Mar;21(3):377-83. doi: 10.1634/theoncologist.2015-0314. Epub 2016 Feb 11.
9
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.经济学与造血干细胞移植后的结果:一项回顾性队列研究。
EBioMedicine. 2015 Nov 19;2(12):2101-9. doi: 10.1016/j.ebiom.2015.11.021. eCollection 2015 Dec.
10
Beyond Biology: Impact of Center- and Country-specific Economic Factors on Outcomes After Hematopoietic Cell Transplantation.超越生物学范畴:特定中心及国家的经济因素对造血细胞移植后结局的影响
EBioMedicine. 2015 Dec 12;2(12):1869-70. doi: 10.1016/j.ebiom.2015.12.005. eCollection 2015 Dec.